CRISPR method efficiently corrects DMD defect in heart tissue
Scientists have developed a CRISPR gene-editing technique that can potentially correct a majority of mutations that cause DMD...
List view / Grid view
Scientists have developed a CRISPR gene-editing technique that can potentially correct a majority of mutations that cause DMD...
SMi Reports: SMi’s 2nd annual Drug Discovery conference, taking place in London on 21 and 22 March 2018, will discuss the role of artificial intelligence in drug discovery.
Researchers have identified an enzyme that appears to drive the conversion of normal colon tissue into cancer...
Researchers have developed a system to model Huntington's in human embryonic stem cells...
Researchers have turned skin cells from mice into stem cells by activating Sox2 and Oct4 using CRISPR technology...
Researchers use CRISPR-Cas9 to target a mutation in the Tmc1 gene that causes the loss of hair cells in the inner ear.
Drug discovery from concept to drug candidate has become a collective effort where multi-disciplinary project teams from CROs work with drug companies and academia to deliver clinical candidates, overcoming multi-factorial research obstacles along the way.
Charles River Laboratories International, Inc. announced the expansion of its CRISPR/Cas9 service offering with the addition of a license from ERS Genomics Limited.
An unexpected drug target for acute myeloid leukaemia could open new avenues to develop effective treatments against the potentially lethal disease...
Nanomapping technology may transform the way disease-causing genetic mutations are diagnosed and discovered...
New delivery system deletes disease-causing genes and reduces cholesterol...
Changing the epigenetic code of a single gene is enough to cause a healthy breast cell to become abnormal...
Charles River Laboratories International, Inc. announced that its team of neuroscience drug discovery experts is presenting 27 scientific posters, both independently and collaboratively with clients, at Neuroscience 2017, the 47th annual meeting of the Society for Neuroscience (SfN).
New 'REPAIR' system edits RNA, rather than DNA, without permanently affecting the genome...
CRISPR used to identify a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic than conventional therapies...